載入...
Telaprevir to Boceprevir Switch Highlights Lack of Cross-Reactivity
Hepatitis C viral protease inhibitors increase sustained virologic response rates compared to interferon and ribavirin but also add side effects. Telaprevir and boceprevir are structurally similar, and share cross-resistant mutations. This case report highlights successful management of telaprevir s...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732052/ https://ncbi.nlm.nih.gov/pubmed/23166191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis960 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|